THE APAPP BLOG

Breathing is an automatic function of our body, yet for many, it can be a complex and challenging process. In her insightful […]

The National Board for Respiratory Care is offering a buy one, get a second chance guaranteed on their Certified Asthma Educator (AE-C) […]

As the Fall season arrives, there are increasing challenges for patients with asthma. Between an increased incidence of respiratory viruses, fall allergen […]

The Association of Pulmonary Advanced Practice Providers (APAPP) and Pulmonx Corporation are excited to announce a new partnership focused on providing APP’s […]

November is National COPD Awareness Month, and the Association of Pulmonary Advanced Practice Providers (APAPP) is committed to empowering both patients and […]

As the physician shortage across the US continues to grow, the demand for medical care remains a void that needs to be […]

In this episode, we interview Erin Klein Carlson, a respiratory therapist, about the basics of pulmonary function testing. We discuss the reasons […]

Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA.

Author Corinne Young View all posts

Author APAPP Staff This post was published by The APAPP staff on behalf of the author(s) – listed above. View all […]

Author Corinne Young View all posts

In a recent PeerDirect program from Boehringer Ingelheim, Corinne Young, MSN, FNP-C, FCCP, and Jessica Glennie, CNP discuss the role of Advanced […]

Over the last several years, the role of the Advanced Practice Provider (APP) in the ICU has been evolving. As intensivist models have developed across the country, it has become apparent for the need for continuous provider coverage in the ICU and APPs have filled this gap.

Pulmonary hypertension is a rare condition, and even rarer is pulmonary arterial hypertension.

I just got back from the CHEST annual meeting and I can say that it was by far the best conference I have ever attended; it had content extremely pertinent to my practice.

“Why is Rachel seeing that patient…They don’t have asthma?!” Ding, ding, ding… Have you ever had a moment where you heard something that made you stop in your tracks and realize you needed to take action?

Author Lolita Melhado Lolita Melhado PhD, APRN, FNP-BC, ACHPN is a leader, educator, researcher, and author. She earned a PhD in nursing […]

Author Amy Carlson Amy Carlson is a wife to Major (retired) Jason Carlson and mom to 3 lucky kids (that are now […]

Author Katherine Rosen Katie Rosen, RN, MSN, ANP-C, is a nurse practitioner at in the ILD clinic at National Jewish Health in […]

“Why is Rachel seeing that patient…They don’t have asthma?!” Ding, ding, ding… Have you ever had a moment where you heard something that made you stop in your tracks and realize you needed to take action?

APAPP is excited to announce the appointment of Alexandra Kacena, APRN-NP, CPNP-PC, and Emily Simmons, APRN-NP, CPNP-PC, as our new Pediatric Pulmonary […]

Author APAPP Staff This post was published by The APAPP staff on behalf of the author(s) – listed above. View all […]

Author APAPP Staff This post was published by The APAPP staff on behalf of the author(s) – listed above. View all […]